036480 — Daesung Microbiological Labs Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Daesung Microbiological Labs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9,935	12,859	11,727	9,053	9,388
Net Total Accounts Receivable
Net Total Receivables	3,114	3,251	4,285	3,958	5,187
Total Inventory
Prepaid Expenses
Total Current Assets	23,722	28,690	28,717	23,641	25,234
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35,846	33,303	32,124	31,944	29,950
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	62,620	65,109	64,290	58,379	57,979
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,315	10,611	10,398	4,530	8,532
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	25,616	26,272	26,942	23,230	22,558
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	37,004	38,837	37,349	35,149	35,421
Total Liabilities & Shareholders' Equity	62,620	65,109	64,290	58,379	57,979
Total Common Shares Outstanding